Taurine for Longevity: What the Science Actually Says in 2026

Taurine is a conditionally essential sulfonic amino acid, abundant in muscle, retina, brain, and heart, that the body can synthesise but in declining amounts with age. It is found almost exclusively in animal products, so vegans and vegetarians typically have substantially lower levels.

A landmark 2023 Science paper by Yadav et al. showed that taurine levels fall by ~80% from youth to old age in mice, monkeys, and humans. In mice, taurine supplementation from middle age extended median lifespan by 10–12% and improved multiple hallmarks of aging (bone density, muscle strength and endurance, fat accumulation, glucose control, mood-related behaviour, and memory). In monkeys, 6 months of taurine improved bone density, reduced DNA damage markers and liver fat, and improved fasting glucose. In humans, lower taurine levels correlated with obesity, hypertension, inflammation, and type 2 diabetes, though these data are observational and not causal.

Beyond longevity, taurine has human RCT evidence for several domains:

• Cardiovascular: ≥1 g/day lowers blood pressure by ~4/2 mmHg in hypertensive individuals; 3 g/day improves exercise capacity and cardiac function in heart failure; modest, mixed effects on LDL.
• Exercise: 1–6 g taken pre-exercise modestly improves endurance and reduces DOMS, likely via calcium handling, osmolyte effects, and indirect antioxidant activity.
• Glycaemic control: Small trials in type 2 diabetes show reductions in fasting glucose and HbA1c, with mechanisms involving insulin sensitivity, β-cell support, and reduced oxidative stress.
• Eye and neuroprotection: Taurine is critical for retinal function and acts as a neuromodulator at GABA-A and glycine receptors, with plausible roles in retinal health, anxiolysis, and protection against excitotoxicity, though human cognitive/AMD data are limited.

Mechanistically, taurine interacts with other longevity strategies but is not redundant: it complements NAD+ precursors (NMN/NR), mitochondrial supports (CoQ10, ALCAR), and creatine, particularly for muscle and metabolic health.

Dosing in animal studies translates to roughly 500 mg–3 g/day in humans; most human trials use 1–3 g/day. A practical range is 1–2 g/day, up to 3 g/day, with no strong timing requirements. EFSA considers up to 6 g/day safe; up to 10 g/day has been used without major adverse effects. Taurine has no well-established drug interactions, though people on antihypertensives should monitor blood pressure.

Those most likely to benefit include adults 40+, vegans/vegetarians, people with cardiovascular risk or heart failure, athletes, and individuals with type 2 diabetes. Young, healthy omnivores with high animal-protein intake may see less obvious benefit.

The major unknown is whether taurine supplementation extends human lifespan or significantly reduces age-related disease in long-term RCTs; current longevity evidence in humans is mechanistic and correlational, not definitive. Nonetheless, given its safety, low cost, and RCT-backed benefits in cardiovascular, exercise, and metabolic domains, taurine is a rational inclusion in an evidence-based longevity or health optimisation stack for most adults, especially those over 40 and vegans. Practical use: 1–3 g/day of free-form taurine powder or capsules, taken with meals and combined with lifestyle measures and complementary supplements such as creatine and CoQ10.